Clinical Implications of Early Patent Ductus Arteriosus Closure

Дата публикации: 01-08-2026 00:00:00

To the Editor We read with great interest the Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen (TREOCAPA) trial by Rozé et al evaluating prophylactic acetaminophen for patent ductus arteriosus (PDA) in extremely preterm infants. This rigorously designed trial provides important evidence for this long-standing controversy, while provoking profound reflections on PDA pathophysiology and therapeutic strategies.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Clinical Implications of Early Patent Ductus Arteriosus Closure—Reply	0	5.5	01-08-2026
2	Clinical Implications of Early Patent Ductus Arteriosus Closure	0	12.14	01-08-2026
3	Caffeine for Hypoxic Ischemic Encephalopathy	0	10.38	01-08-2026
4	Tylenol use in pregnancy is NOT linked to 'significant' risk of autism, new study finds	0	10.35	15-04-2026
5	Lacrimal Sac Massage vs Probing for Congenital Nasolacrimal Duct Obstruction	0	4.05	13-08-2026
6	Major study challenges long-held fears about acetaminophen and ibuprofen use in babies	0	10.75	06-08-2026
7	Erythropoietin for Neonatal Hypoxic-Ischemic Encephalopathy	0	13.05	27-07-2026
8	Considerations Regarding Valved Holding Chamber Efficiency	0	7.7	01-08-2026
9	Standardizing Conservative Treatment for Congenital Nasolacrimal Duct Obstruction	0	6.71	13-08-2026
10	Prone Positioning in Infants With Acute Bronchiolitis Research Summary	0	9.96	28-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.44. Источник: archderm.jamanetwork.com.